Location · Lake Charles, LA
Clinical trials in Lake Charles, LA
20 recruiting studies have a site in Lake Charles, and 0 of them accept healthy volunteers.
20 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Lake Charles, LA + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Lake Charles, LA + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Vor Biopharma
- Location
- Lake Charles, LA + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Hoffmann-La Roche
- Location
- Lake Charles, LA + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis
Madrigal Pharmaceuticals, Inc.
- Location
- Lake Charles, LA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
UCB Biopharma SRL
- Location
- Lake Charles, LA + 61 other US sites
- Eligibility basics
- Ages 16+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Lake Charles, LA + 45 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Morphic Medical Inc.
- Location
- Lake Charles, LA + 25 other US sites
- Eligibility basics
- Ages 22–65
- RecruitingPhase 3
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Novartis Pharmaceuticals
- Location
- Lake Charles, LA + 20 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Lake Charles, LA + 90 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Hoffmann-La Roche
- Location
- Lake Charles, LA + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
AstraZeneca
- Location
- Lake Charles, LA + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
AbbVie
- Location
- Lake Charles, LA + 48 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
EMD Serono Research & Development Institute, Inc.
- Location
- Lake Charles, LA + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Janssen Research & Development, LLC
- Location
- Lake Charles, LA + 37 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Eli Lilly and Company
- Location
- Lake Charles, LA + 40 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
GlaxoSmithKline
- Location
- Lake Charles, LA + 1 other US site
- Eligibility basics
- Ages 40–80
- RecruitingPhase 4
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Aurinia Pharmaceuticals Inc.
- Location
- Lake Charles, LA + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Lake Charles, LA + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
- Location
- Lake Charles, LA + 41 other US sites
- Eligibility basics
- Ages 55+